ACADIA Pharmaceuticals Inc. (ACAD) stock is down -58.61% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ACAD stock a score of 32 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 2. ACAD's rank also includes a fundamental score of 32. In addition to the average rating from Wall Street analysts, ACAD stock has a mean target price of $28.94. This means analysts expect the stock to add 29.62% over the next 12 months. The long-term technical score for ACAD is 62.
ACAD has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ACAD!
ACADIA Pharmaceuticals Inc. (ACAD) stock is higher by 5.43% while the S&P 500 is down -0.5% as of 3:38 PM on Monday, Jan 24. ACAD is higher by $1.15 from the previous closing price of $21.18 on volume of 1,660,382 shares. Over the past year the S&P 500 has risen 13.51% while ACAD is down -58.61%. ACAD lost -$1.20 per share in the over the last 12 months.
Click Here to get the full Stock Report for ACADIA Pharmaceuticals Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
